Advanced Biomed Inc.
ADVB
$4.95
$0.4910.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 44.85% | 49.30% | -- | -- |
| Total Depreciation and Amortization | -- | -25.47% | -17.54% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -- | 70.06% | 56.90% | -- | -- |
| Cash from Operations | -- | 60.47% | 54.72% | -305.04% | -2,734.34% |
| Capital Expenditure | -- | 91.04% | -813.64% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 91.04% | -813.64% | -120.56% | 153.50% |
| Total Debt Issued | -- | 153.85% | -31.29% | -- | -- |
| Total Debt Repaid | -- | 98.66% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -199.40% | -- | -- |
| Cash from Financing | -- | 158.46% | -112.98% | 1,344.77% | 4.03% |
| Foreign Exchange rate Adjustments | -- | -267.41% | 24.43% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 89.15% | -190.24% | 24,673.53% | -73.85% |